A Study of MK-3415, MK-6072, and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-001)

Clinical trial NCT01241552 · COMPLETED

Trial details

NCT number: NCT01241552
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Clostridium Difficile Infection

Start date: 2011-10-10
Primary completion: 2014-12-09
Enrollment: 1452

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.